NuvOx Pharma Overview

  • Year Founded
  • 2008

Year Founded

  • Status
  • Private

  • Employees
  • 10

Employees

  • Latest Deal Type
  • Series B

  • Latest Deal Amount
  • $1.2M

  • Investors
  • 17

NuvOx Pharma General Information

Description

Developer of oxygen therapeutics designed to treat life-threatening diseases. The company is developing a drug that improves the flow of oxygen from the lungs to the blood and from blood to tissue, enabling medical practitioners to improve oxygen delivery in the bloodstream to help treat life-threatening conditions.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Corporate Office
  • 1635 East 18th Street
  • Tucson, AZ 85719
  • United States
+1 (520) 000-0000

NuvOx Pharma Timeline

2021202220232024
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

NuvOx Pharma Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
18. Later Stage VC (Series B) 01-Oct-2023 $1.2M 000.00 Completed Generating Revenue
17. Grant 24-Apr-2023 00000 000.00 Completed Generating Revenue
16. Later Stage VC 31-Dec-2022 000.00 000.00 000.00 Completed Generating Revenue
15. Grant 15-Sep-2021 00000 00.000 Completed Clinical Trials - Phase 2
14. Debt - PPP 03-May-2020 00.000 Completed Clinical Trials - Phase 2
13. Grant 15-Jul-2018 00.000 00.000 Completed Clinical Trials - Phase 2
12. Grant 29-Sep-2017 000 00.000 Completed Clinical Trials - Phase 2
11. Later Stage VC 01-Sep-2017 000 00.000 Completed Clinical Trials - Phase 2
10. Grant 27-Aug-2016 $240K $4.36M Completed Clinical Trials - Phase 2
9. Grant 08-Mar-2016 $110K $4.36M Completed Clinical Trials - Phase 2
To view NuvOx Pharma’s complete valuation and funding history, request access »

NuvOx Pharma Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of oxygen therapeutics designed to treat life-threatening diseases. The company is developing a drug that impr
Drug Discovery
Tucson, AZ
10 As of 2022
000.00
00000000000 000.00

000000

mod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam,
0000 000000000
Vienna, Austria
00.00
0000000000 00.00

000000

in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint
0000000000000
Redwood City, CA
000 As of 0000
00000
000000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

NuvOx Pharma Competitors (35)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Apeptico Venture Capital-Backed Vienna, Austria 00.00 0000000000 00.00
Adverum Biotechnologies Formerly VC-backed Redwood City, CA 000 00000 000000000 00000
NexImmune Formerly VC-backed Gaithersburg, MD 00 00000 00000000 00000
WaVe Life Sciences Formerly VC-backed Cambridge, MA 000 00.000 00000000 00.000
Vertex Pharmaceuticals Formerly VC-backed Boston, MA 0000 00.000 000000&0
You’re viewing 5 of 35 competitors. Get the full list »

NuvOx Pharma Patents

NuvOx Pharma Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20190365665-A1 Iso-osmotic and near iso-osmotic oxygen therapeutic formulations and methods thereof Pending 24-Jan-2017 00000000 0
JP-6936226-B2 Fluorocarbon nanoemulsion composition Active 21-Dec-2015 0000000000
US-20180360754-A1 Compositions of fluorocarbon nanoemulsion, and methods of preparation and use thereof Active 21-Dec-2015 0000000000 0
EP-3393459-A1 Compositions of fluorocarbon nanoemulsion, and methods of preparation and use thereof Pending 21-Dec-2015 0000000000 0
EP-3393459-A4 Compositions of fluorocarbon nanoemulsion, and methods of preparation and use thereof Pending 21-Dec-2015 A61K9/1075 0
To view NuvOx Pharma’s complete patent history, request access »

NuvOx Pharma Executive Team (11)

Name Title Board Seat Contact Info
Rong Wang Chief Financial Officer, Chief Operating Officer & President
Jennifer Johnson Ph.D Co-Founder & Chief Scientific Officer
Evan Unger MD Co-Founder, Chief Executive Officer, President & Board Member
You’re viewing 3 of 11 executive team members. Get the full list »

NuvOx Pharma Board Members (6)

Name Representing Role Since
Evan Unger MD Self Co-Founder, Chief Executive Officer, President & Board Member 000 0000
Jon Saxe JD Self Board Member 000 0000
Jonathan Schilling Self Board Member 000 0000
Marvin Slepian MD Self Board Member 000 0000
Richard Carmona MD Self Board Member 000 0000
You’re viewing 5 of 6 board members. Get the full list »

NuvOx Pharma Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

NuvOx Pharma Investors (17)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Band of Angels Angel Group 000 0000 000000 0
K2X Corporation 000 0000 000000 0
Keiretsu Capital Venture Capital Minority 000 0000 000000 0
New World Angels Angel Group 000 0000 000000 0
TCA Venture Group Angel Group 000 0000 000000 0
You’re viewing 5 of 17 investors. Get the full list »

NuvOx Pharma FAQs

  • When was NuvOx Pharma founded?

    NuvOx Pharma was founded in 2008.

  • Who is the founder of NuvOx Pharma?

    Jennifer Johnson Ph.D, David Wilson Ph.D, and Evan Unger MD are the founders of NuvOx Pharma.

  • Who is the CEO of NuvOx Pharma?

    Evan Unger MD is the CEO of NuvOx Pharma.

  • Where is NuvOx Pharma headquartered?

    NuvOx Pharma is headquartered in Tucson, AZ.

  • What is the size of NuvOx Pharma?

    NuvOx Pharma has 10 total employees.

  • What industry is NuvOx Pharma in?

    NuvOx Pharma’s primary industry is Drug Discovery.

  • Is NuvOx Pharma a private or public company?

    NuvOx Pharma is a Private company.

  • What is NuvOx Pharma’s current revenue?

    The current revenue for NuvOx Pharma is 000000.

  • How much funding has NuvOx Pharma raised over time?

    NuvOx Pharma has raised $19.7M.

  • Who are NuvOx Pharma’s investors?

    Band of Angels, K2X, Keiretsu Capital, New World Angels, and TCA Venture Group are 5 of 17 investors who have invested in NuvOx Pharma.

  • Who are NuvOx Pharma’s competitors?

    Apeptico, Adverum Biotechnologies, NexImmune, WaVe Life Sciences, and Vertex Pharmaceuticals are some of the 35 competitors of NuvOx Pharma.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »